HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.

Abstract
Levels of antibodies to the capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b were determined by radioimmunoassay in acute- and convalescent-phase sera of 377 patients with meningitis, septicemia, or epiglottitis. Diagnostic criteria, based on a fourfold or greater rise in antibody level and/or a high specific antibody level, correctly identified 85% of group A meningococcal diseases, 90% of group C meningococcal diseases, and 78% of H. influenzae type b diseases in children older than but only 15% in infants younger than 1.5 years of age. When levels of antibody in acute-phase sera were high, they were predominantly of the IgA class. A greater than fourfold rise in levels of antibodies to group A meningococcus was seen in 10%-32% of persons with disease caused by other bacteria, but minimal false-positive reactions occurred with group C meningococcus or H. influenzae type b.
AuthorsH Käyhty, H Jousimies-Somer, H Peltola, P H Mäketä
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 143 Issue 1 Pg. 32-41 (Jan 1981) ISSN: 0022-1899 [Print] United States
PMID6783703 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulins
  • Polysaccharides, Bacterial
Topics
  • Acute Disease
  • Antibodies, Bacterial (analysis)
  • Child, Preschool
  • Haemophilus influenzae (immunology)
  • Humans
  • Immunoglobulins (analysis)
  • Infant
  • Laryngitis (immunology)
  • Meningitis, Haemophilus (immunology)
  • Neisseria meningitidis (immunology)
  • Polysaccharides, Bacterial (immunology)
  • Sepsis (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: